Health Affairs, 28, no. 4 (2009): 948
doi: 10.1377/hlthaff.28.4.948
© 2009 by Project HOPE
 
New Online
 * Reinhardt: Post-Summit
 * Report from the Summit
 * President's Reform Proposal
 * Rising Medicare Costs
 * Spending for Immigrants
 * $2.5 Trillion U.S. Health Tab
 * Child Obesity Briefing
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
PubMed
* PubMed Citation
Related Collections
* International Issues
* Physicians
* Research And Technology

Tools & Technologies

PROLOGUE

Spreading Tools And Technologies


The first 100 words of the full text of this article appear below.

New drugs, vaccines, and diagnostic tests could save millions of lives each year in the developing world, but organizations wishing to deliver them will confront a multifaceted problem: how to get products to people who need them most. Target populations may lack access to health clinics or other venues where they can obtain needed therapies. Manufacturers may not want to develop products without the promise of reasonable profits. Then there’s the problem of managing the many players—international, national, and local—that must cooperate in creating a product and getting it to the user. The papers in this section examine lessons learned . . . [Full Text of this Article]


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?